Pharmx Technologies Ltd Asset Resilience Ratio
Pharmx Technologies Ltd asset resilience ratio. Pharmx Technologies Ltd (PHX) has an Asset Resilience Ratio of 22.16% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Pharmx Technologies Ltd debt and liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Pharmx Technologies Ltd (1994–2024)
Asset resilience ratio of Pharmx Technologies Ltd from 1994 to 2024. This chart shows how Pharmx Technologies Ltd's Asset Resilience Ratio has changed over time. See PHX cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Liquid Assets Composition Over Time
This chart breaks down Pharmx Technologies Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Pharmx Technologies Ltd total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$4.17 Million | 22.16% |
| Short-term Investments | AU$0.00 | 0% |
| Total Liquid Assets | AU$4.17 Million | 22.16% |
Asset Resilience Insights
- Good Liquidity Position: Pharmx Technologies Ltd maintains a healthy 22.16% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Pharmx Technologies Ltd Industry Peers by Asset Resilience Ratio
Compare Pharmx Technologies Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Hinge Health, Inc.
NYSE:HNGE |
Health Information Services | 12.47% |
|
Kneat.com Inc
TO:KSI |
Health Information Services | 0.37% |
|
Oneview Healthcare Plc
AU:ONE |
Health Information Services | 29.71% |
|
Singular Health Group Ltd
AU:SHG |
Health Information Services | 66.96% |
|
Medadvisor Ltd
AU:MDR |
Health Information Services | 12.37% |
|
Trivarx Ltd
AU:TRI |
Health Information Services | 2.55% |
|
Pro Medicus Ltd
AU:PME |
Health Information Services | 17.07% |
|
Cogstate Ltd
AU:CGS |
Health Information Services | 54.90% |
Pharmx Technologies Ltd Asset Resilience Ratio by Year (1994–2024)
Pharmx Technologies Ltd asset resilience ratio by year from 1994 to 2024. The table below shows the annual Asset Resilience Ratio data for Pharmx Technologies Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-06-30 | 42.05% | AU$12.56 Million ≈ $8.88 Million |
AU$29.86 Million ≈ $21.13 Million |
-26.60pp |
| 2023-06-30 | 68.65% | AU$25.07 Million ≈ $17.74 Million |
AU$36.52 Million ≈ $25.84 Million |
+34.51pp |
| 2022-06-30 | 34.14% | AU$10.50 Million ≈ $7.43 Million |
AU$30.77 Million ≈ $21.77 Million |
+13.47pp |
| 2021-06-30 | 20.67% | AU$6.48 Million ≈ $4.58 Million |
AU$31.35 Million ≈ $22.18 Million |
+8.55pp |
| 2020-06-30 | 12.11% | AU$2.32 Million ≈ $1.64 Million |
AU$19.18 Million ≈ $13.57 Million |
-3.40pp |
| 2019-06-30 | 15.51% | AU$2.33 Million ≈ $1.65 Million |
AU$15.04 Million ≈ $10.64 Million |
-9.69pp |
| 2018-06-30 | 25.20% | AU$4.97 Million ≈ $3.52 Million |
AU$19.73 Million ≈ $13.96 Million |
-15.79pp |
| 2017-06-30 | 40.99% | AU$8.10 Million ≈ $5.73 Million |
AU$19.76 Million ≈ $13.98 Million |
+38.68pp |
| 1995-06-30 | 2.31% | AU$246.00K ≈ $174.06K |
AU$10.64 Million ≈ $7.53 Million |
-3.14pp |
| 1994-06-30 | 5.45% | AU$796.00K ≈ $563.22K |
AU$14.61 Million ≈ $10.34 Million |
-- |
About Pharmx Technologies Ltd
PharmX Technologies Limited, together with its subsidiaries, operates as a technology and software development company in Australia. It also operates PharmX, an electronic ordering and invoicing gateway; PharmX Marketplace, an e-commerce ordering platform; PharmX Analytics which provides insights for operations of supplier and pharmacy customers. The company was formerly known as Corum Group Limi… Read more